-
- Hiroo Katsuya
- Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan;
-
- Kenji Ishitsuka
- Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan;
-
- Atae Utsunomiya
- Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan;
-
- Shuichi Hanada
- Department of Hematology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan;
-
- Tetsuya Eto
- Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan;
-
- Yukiyoshi Moriuchi
- Department of Hematology, Sasebo City General Hospital, Sasebo, Japan;
-
- Yoshio Saburi
- Department of Hematology, Oita Prefectural Hospital, Oita, Japan;
-
- Masaharu Miyahara
- Department of Internal Medicine, Karatsu Red Cross Hospital, Karatsu, Japan;
-
- Eisaburo Sueoka
- Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan;
-
- Naokuni Uike
- Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan;
-
- Shinichiro Yoshida
- Department of Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan;
-
- Kiyoshi Yamashita
- Department of Internal Medicine, Miyazaki Prefectural Hospital, Miyazaki, Japan;
-
- Kunihiro Tsukasaki
- Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan;
-
- Hitoshi Suzushima
- Department of Hematology, Kumamoto Shinto General Hospital, Kumamoto, Japan;
-
- Yuju Ohno
- Department of Internal Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan;
-
- Hitoshi Matsuoka
- Department of Internal Medicine, Koga General Hospital, Miyazaki, Japan;
-
- Tatsuro Jo
- Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan;
-
- Masahiro Amano
- Department of Dermatology, Miyazaki University, Miyazaki, Japan;
-
- Ryosuke Hino
- Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan;
-
- Mototsugu Shimokawa
- Clinical Research Institute, National Kyushu Cancer Center, Fukuoka, Japan;
-
- Kazuhiro Kawai
- Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan; and
-
- Junji Suzumiya
- Cancer Center, Shimane University Hospital, Izumo, Japan
-
- Kazuo Tamura
- Division of Medical Oncology, Hematology and Infectious Diseases, Department of Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan;
抄録
<jats:title>Key Points</jats:title> <jats:p>An improvement of 4-year OS for acute and lymphoma types of ATL was observed in comparison with that of the 1991 report. The prognosis of the smoldering type ATL was worse than expected from the 1991 report.</jats:p>
収録刊行物
-
- Blood
-
Blood 126 (24), 2570-2577, 2015-12-10
American Society of Hematology